Instem proves in step with
groundbreaking market needs as it
posts strong 2022 performance

Proactive interview with Phil Reason,
Instem CEO

Investor Meet Company: Results and Company Update
September 2022

Presentation now available to watch on-demand

Watch Now

A global provider of leading software solutions
and services to the life sciences community.

The future transformed for the benefit of everyone.
Intelligent solutions empowering collaboration and life-enhancing science.

Learn more

Creating a more connected ecosystem in the
life sciences industry by consolidating and
harmonizing a fragmented IT marketplace.

Learn more

Welcome to the Instem Investor Centre

Instem (AIM:INS.L) is a leading provider of IT solutions and services to the global early development healthcare market, delivering compelling solutions for data collection, analysis and regulatory submissions management.

RECOMMENDED CASH ACQUISITION ("ACQUISITION") OF INSTEM PLC ("INSTEM") BY ICHOR MANAGEMENT LIMITED ("BIDCO")

Latest News

25 September 2023 - Publication of Scheme Document

Read More

19 September 2023 - Grant of PDMR Options

Read More

15 September 2023 - Half Year Report

Read More

Annual Report 2022

H1 23 – another strong trading performance

Annual Report 2022

H1 23 – another strong trading performance

Research Note by Gareth Evans of Progressive Equity Research